Prices are updated after-hours


Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date

for   symbols : Nvs    save search

New Novartis Fabhalta® (iptacopan) data show clinically meaningful and statistically significant proteinuria reduction of 38.3% versus placebo for patients with IgA nephropathy (IgAN)
Published: 2024-04-15 (Crawled : 18:00) - globenewswire.com
NVS | News | $98.12 3.15% 1.1M twitter stocktwits trandingview |
Health Technology
| | O: -1.46% H: 0.0% C: 0.0%

fabhalta nephropathy for novartis show
Arvinas Enters into a Transaction with Novartis, including a Global License Agreement for the Development and Commercialization of PROTAC® Androgen Receptor (AR) Protein Degrader ARV-766 for the Treatment of Prostate Cancer
Published: 2024-04-11 (Crawled : 11:00) - globenewswire.com
NVS | News | $98.12 3.15% 1.1M twitter stocktwits trandingview |
Health Technology
| | O: 0.32% H: 0.04% C: -0.56%
ARVN | $35.24 0.97% 67K twitter stocktwits trandingview |
Health Technology
| | O: 8.28% H: 0.56% C: -4.75%

arv-766 protac license cancer treatment global protein for commercialization agreement
Novartis tender offer for MorphoSys AG commences
Published: 2024-04-11 (Crawled : 09:00) - globenewswire.com
NVSEF | News | $95.11 490 twitter stocktwits trandingview |
Health Technology
| | O: -0.32% H: 0.48% C: -0.17%
NVS | News | $98.12 3.15% 1.1M twitter stocktwits trandingview |
Health Technology
| | O: 0.32% H: 0.04% C: -0.56%
MOR | News | $18.06 0.56% 35K twitter stocktwits trandingview |
Health Technology
| | O: 0.69% H: 0.0% C: -0.39%

for novartis
LASIK Surgery Market size to record USD 1.24 bn growth from 2024-2028, Increasing medical tourism for LASIK surgery is one of the key market trends, Technavio
Published: 2024-03-28 (Crawled : 22:00) - prnewswire.com
NVS | News | $98.12 3.15% 1.1M twitter stocktwits trandingview |
Health Technology
| Email alert Add to watchlist
ABT | News | $107.565 0.46% 610K twitter stocktwits trandingview |
Health Technology
| Email alert Add to watchlist
ALC | $81.08 0.58% 180K twitter stocktwits trandingview |
Health Technology
| Email alert Add to watchlist
NVSEF | News | $95.11 490 twitter stocktwits trandingview |
Health Technology
| Email alert Add to watchlist

one key medical growth market
Novartis Fabhalta® (iptacopan) receives positive CHMP opinion as first oral monotherapy for adult patients with paroxysmal nocturnal hemoglobinuria (PNH)
Published: 2024-03-22 (Crawled : 12:00) - globenewswire.com
NVS | News | $98.12 3.15% 1.1M twitter stocktwits trandingview |
Health Technology
| | O: 0.17% H: 0.28% C: -0.01%

fabhalta first chmp positive novartis
Global OTC Artificial Tears Analysis Report 2023-2030: The Influence of Smart Technologies, Market Positioned for Continued Expansion Amid Growing Focus on Eye Wellness
Published: 2024-03-21 (Crawled : 00:00) - prnewswire.com
NVS | News | $98.12 3.15% 1.1M twitter stocktwits trandingview |
Health Technology
| | O: 0.17% H: 0.28% C: -0.01%
JNJ | News | $148.24 -0.59% 1.6M twitter stocktwits trandingview |
Health Technology
| | O: 0.02% H: 0.0% C: 0.0%
BHC | $8.535 1.01% 480K twitter stocktwits trandingview |
Health Technology
| | O: -0.74% H: 1.54% C: 1.38%
ABBV | News | $169.965 1.24% 890K twitter stocktwits trandingview |
Health Technology
| | O: 0.16% H: 0.0% C: 0.0%

report expansion global wellness smart growing eye market
Adaptimmune Hires Chief Commercial Officer in Advance of Q3 2024 PDUFA Date for Afami-cel, a Late-stage Product in the Company's Sarcoma Franchise
Published: 2024-02-27 (Crawled : 15:30) - biospace.com/
TSVT | $4.835 3.98% 96K twitter stocktwits trandingview |
| | O: 0.0% H: 8.64% C: 8.36%
NVS | News | $98.12 3.15% 1.1M twitter stocktwits trandingview |
Health Technology
| | O: -0.15% H: 0.31% C: 0.06%
BLBD | $36.12 6.3% 85K twitter stocktwits trandingview |
Producer Manufacturing
| | O: 1.02% H: 1.29% C: 1.17%
ALVR | $0.763 7.7K twitter stocktwits trandingview |
Health Technology
| | O: -1.42% H: 7.9% C: 3.52%
ADAP | $1.08 6.93% 160K twitter stocktwits trandingview |
Health Technology
| | O: 3.05% H: 5.92% C: 1.18%

pdufa commercial
Insulin Pen Global Market Outlook Report 2024-2028: Current Market Size and Revenue Growth Prospects for Insulin Pens, with Market Share Analysis by Type, Onset Time, End User and Geographical Region
Published: 2024-02-23 (Crawled : 17:00) - prnewswire.com
NVSEF | News | $95.11 490 twitter stocktwits trandingview |
Health Technology
| | O: 0.37% H: 0.58% C: 0.58%
VTRS | News A | $11.34 0.8% 900K twitter stocktwits trandingview |
Health Technology
| | O: 0.0% H: 1.93% C: 1.27%
NVO | News | $127.41 1.72% 750K twitter stocktwits trandingview |
Health Technology
| | O: -0.68% H: 0.4% C: -0.18%
NVS | News | $98.12 3.15% 1.1M twitter stocktwits trandingview |
Health Technology
| | O: 0.89% H: 0.4% C: 0.17%
JNJ | News | $148.24 -0.59% 1.6M twitter stocktwits trandingview |
Health Technology
| | O: 0.28% H: 0.0% C: 0.0%
SNY | News | $47.375 0.48% 300K twitter stocktwits trandingview |
Health Technology
| | O: 0.97% H: 0.0% C: 0.0%

report revenue global insulin growth market
Erasca Announces Two Clinical Trial Collaboration and Supply Agreements for Trametinib to Evaluate Naporafenib Combination in SEACRAFT-1 and SEACRAFT-2 Trials
Published: 2024-02-14 (Crawled : 13:00) - globenewswire.com
ERAS | $1.92 3.78% 120K twitter stocktwits trandingview |
| | O: 2.99% H: 2.03% C: 0.58%
NVS | News | $98.12 3.15% 1.1M twitter stocktwits trandingview |
Health Technology
| | O: -0.02% H: 0.24% C: 0.01%

trials collaboration trial
Hydroxychloroquine Market to Reach $2.86 Billion by 2028 Amidst Rising Demand for Autoimmune Disease Treatments
Published: 2024-02-13 (Crawled : 00:00) - prnewswire.com
SNYNF | News | $92.7 600K twitter stocktwits trandingview |
Health Technology
| | O: -2.71% H: 0.0% C: 0.0%
NVS | News | $98.12 3.15% 1.1M twitter stocktwits trandingview |
Health Technology
| | O: -0.02% H: 0.24% C: 0.01%
SNY | News | $47.375 0.48% 300K twitter stocktwits trandingview |
Health Technology
| | O: -1.1% H: 0.0% C: 0.0%

disease reach market
Biologic Therapeutics Market to Increase by USD 286.12 billion during 2022-2027, North America to account for 57% of the growth - Technavio
Published: 2024-02-07 (Crawled : 08:00) - prnewswire.com
AZNCF | News | $138.73 3.7K twitter stocktwits trandingview |
Health Technology
| | O: -0.37% H: 0.0% C: 0.0%
NVSEF | News | $95.11 490 twitter stocktwits trandingview |
Health Technology
| | O: 0.41% H: 0.0% C: 0.0%
NVS | News | $98.12 3.15% 1.1M twitter stocktwits trandingview |
Health Technology
| | O: 0.09% H: 0.39% C: -0.36%
GSK | News | $40.995 1.0% 590K twitter stocktwits trandingview |
Health Technology
| | O: 0.43% H: 0.67% C: 0.21%
BAX | $40.755 0.88% 450K twitter stocktwits trandingview |
Health Technology
| | O: 0.21% H: 0.24% C: -1.04%
ABBV | News | $169.965 1.24% 890K twitter stocktwits trandingview |
Health Technology
| | O: 1.48% H: 0.0% C: 0.0%
SNY | News | $47.375 0.48% 300K twitter stocktwits trandingview |
Health Technology
| | O: 1.33% H: 0.0% C: 0.0%
BMRN | $91.615 2.38% 340K twitter stocktwits trandingview |
Health Technology
| | O: -0.38% H: 1.79% C: 0.22%
AZN | News | $70.54 0.59% 1.7M twitter stocktwits trandingview |
Health Technology
| | O: -0.4% H: 0.19% C: -0.33%
AMGN | News | $273.19 0.47% 360K twitter stocktwits trandingview |
Health Technology
| | O: -0.18% H: 0.0% C: -6.22%

america therapeutics growth market
Novartis to strengthen oncology pipeline with agreement to acquire MorphoSys AG for EUR 68 per share or an aggregate of EUR 2.7bn in cash
Published: 2024-02-05 (Crawled : 22:00) - globenewswire.com
NVSEF | News | $95.11 490 twitter stocktwits trandingview |
Health Technology
| | O: 0.72% H: 0.0% C: -1.56%
NVS | News | $98.12 3.15% 1.1M twitter stocktwits trandingview |
Health Technology
| | O: -0.15% H: 0.6% C: 0.42%
MOR | News | $18.06 0.56% 35K twitter stocktwits trandingview |
Health Technology
| | O: 1.39% H: 0.34% C: -7.08%

pipeline acquire novartis agreement
Global Sustained Release Coatings Markets, 2018-2022 and 2023-2028: Growing Demand for Controlled Drug Delivery Boosts Expansion
Published: 2024-02-01 (Crawled : 17:00) - prnewswire.com
GLAXF | News | $20.305 630 twitter stocktwits trandingview |
Health Technology
| | O: -1.29% H: 0.0% C: -1.38%
PFE | News A | $26.32 0.23% 4.4M twitter stocktwits trandingview |
Health Technology
| | O: 0.07% H: 0.83% C: 0.7%
NVS | News | $98.12 3.15% 1.1M twitter stocktwits trandingview |
Health Technology
| | O: 1.55% H: 0.79% C: 0.25%
GSK | News | $40.995 1.0% 590K twitter stocktwits trandingview |
Health Technology
| | O: 1.27% H: 1.87% C: 1.73%
EMN | $96.8 -0.27% 78K twitter stocktwits trandingview |
Process Industries
| | O: 0.79% H: 0.8% C: 0.77%

drug expansion global growing
Antimicrobial Therapeutics Market to grow by USD 51.4 billion from 2022 to 2027, North America accounts for 38% of market growth- Technavio
Published: 2024-01-17 (Crawled : 06:00) - prnewswire.com
CSLLY | $89.17 54K twitter stocktwits trandingview |
n/a
| | O: -0.64% H: 0.54% C: 0.54%
GLAXF | News | $20.305 630 twitter stocktwits trandingview |
Health Technology
| | O: -0.56% H: 0.0% C: 0.0%
SNYNF | News | $92.7 600K twitter stocktwits trandingview |
Health Technology
| | O: -1.83% H: 0.0% C: 0.0%
ALPMY | News | $9.53 690K twitter stocktwits trandingview |
Manufacturing
| | O: -1.74% H: 0.0% C: -1.35%
NVS | News | $98.12 3.15% 1.1M twitter stocktwits trandingview |
Health Technology
| | O: 0.49% H: 0.18% C: 0.04%
GSK | News | $40.995 1.0% 590K twitter stocktwits trandingview |
Health Technology
| | O: -0.08% H: 0.1% C: -0.18%
ABBV | News | $169.965 1.24% 890K twitter stocktwits trandingview |
Health Technology
| | O: -0.15% H: 0.74% C: 0.18%
SNY | News | $47.375 0.48% 300K twitter stocktwits trandingview |
Health Technology
| | O: 0.45% H: 0.06% C: -0.5%

america therapeutics market
Osteoarthritis Therapeutics Market to grow by USD 3.96 billion from 2022-2027, North America to account for 32% of market growth - Technavio
Published: 2024-01-17 (Crawled : 05:00) - prnewswire.com
GLAXF | News | $20.305 630 twitter stocktwits trandingview |
Health Technology
| | O: -0.56% H: 0.0% C: 0.0%
SNYNF | News | $92.7 600K twitter stocktwits trandingview |
Health Technology
| | O: -1.83% H: 0.0% C: 0.0%
VTRS | News A | $11.34 0.8% 900K twitter stocktwits trandingview |
Health Technology
| | O: -1.02% H: 0.95% C: -1.46%
NVS | News | $98.12 3.15% 1.1M twitter stocktwits trandingview |
Health Technology
| | O: 0.49% H: 0.18% C: 0.04%
GSK | News | $40.995 1.0% 590K twitter stocktwits trandingview |
Health Technology
| | O: -0.08% H: 0.1% C: -0.18%
ABT | News | $107.565 0.46% 610K twitter stocktwits trandingview |
Health Technology
| | O: 0.12% H: 0.77% C: 0.27%
SNY | News | $47.375 0.48% 300K twitter stocktwits trandingview |
Health Technology
| | O: 0.45% H: 0.06% C: -0.5%
ANIK | $25.92 -0.12% 5.2K twitter stocktwits trandingview |
Health Technology
| | O: -1.05% H: 3.55% C: 3.31%

america osteoarthritis therapeutics growth market
Global Pseudomonas Aeruginosa Infection Treatment Market Report 2024-2034: Rising Antibiotic Resistance Drives Demand for Pseudomonas Aeruginosa Infection Treatments
Published: 2024-01-17 (Crawled : 02:00) - prnewswire.com
GLAXF | News | $20.305 630 twitter stocktwits trandingview |
Health Technology
| | O: -0.56% H: 0.0% C: 0.0%
SNYNF | News | $92.7 600K twitter stocktwits trandingview |
Health Technology
| | O: -1.83% H: 0.0% C: 0.0%
NVS | News | $98.12 3.15% 1.1M twitter stocktwits trandingview |
Health Technology
| | O: 0.49% H: 0.18% C: 0.04%
JNJ | News | $148.24 -0.59% 1.6M twitter stocktwits trandingview |
Health Technology
| | O: -1.02% H: 0.0% C: 0.0%
GSK | News | $40.995 1.0% 590K twitter stocktwits trandingview |
Health Technology
| | O: -0.08% H: 0.1% C: -0.18%
ABT | News | $107.565 0.46% 610K twitter stocktwits trandingview |
Health Technology
| | O: 0.12% H: 0.77% C: 0.27%
SNY | News | $47.375 0.48% 300K twitter stocktwits trandingview |
Health Technology
| | O: 0.45% H: 0.06% C: -0.5%
GILD | $67.36 0.61% 1.2M twitter stocktwits trandingview |
Health Technology
| | O: -0.19% H: 0.87% C: 0.76%

report infection treatment global market
Electron Microscope Market size to grow by USD 1.68 billion from 2022 to 2027; APAC to account for 55% of market growth- Technavio
Published: 2024-01-16 (Crawled : 09:00) - prnewswire.com
ATEYY | $34.01 3.1M twitter stocktwits trandingview |
n/a
| | O: 1.01% H: 2.93% C: 2.47%
NINOY | $9.88 1.4K twitter stocktwits trandingview |
Manufacturing
| | O: -0.2% H: 0.0% C: -0.99%
TMO | News | $572.645 4.43% 800K twitter stocktwits trandingview |
Health Technology
| | O: -0.89% H: 0.0% C: 0.0%
NVS | News | $98.12 3.15% 1.1M twitter stocktwits trandingview |
Health Technology
| | O: 0.16% H: 0.43% C: 0.07%
KEYS | $146.74 1.38% 200K twitter stocktwits trandingview |
Electronic Technology
| | O: -0.78% H: 0.42% C: -0.04%

market
Allergy Immunotherapies Market to grow by USD 1.01 billion from 2022 to 2027; Europe to account for 53% of market growth - Technavio
Published: 2024-01-16 (Crawled : 03:00) - prnewswire.com
VTRS | News A | $11.34 0.8% 900K twitter stocktwits trandingview |
Health Technology
| | O: -0.6% H: 1.34% C: 1.21%
NVS | News | $98.12 3.15% 1.1M twitter stocktwits trandingview |
Health Technology
| | O: 0.16% H: 0.43% C: 0.07%

europe growth market
Lantheus Announces Acceptance of its First-to-File ANDA for Generic LUTATHERA® (Lutetium Lu 177 Dotatate)
Published: 2024-01-11 (Crawled : 13:00) - globenewswire.com
NVS | News | $98.12 3.15% 1.1M twitter stocktwits trandingview |
Health Technology
| | O: -0.22% H: 0.43% C: 0.37%
LNTH | $64.01 1.49% 52K twitter stocktwits trandingview |
Health Technology
| | O: 0.32% H: 0.03% C: -4.42%

lutathera
Castration-Resistant Prostate Cancer (CRPC) Treatment Market size to grow by USD 5.98 billion from 2023 to 2028, North America to account for 47% of market growth- Technavio
Published: 2024-01-09 (Crawled : 03:00) - prnewswire.com
ALPMF | News | $9.75 200 twitter stocktwits trandingview |
Health Technology
| | O: 0.16% H: 0.0% C: -3.88%
NVSEF | News | $95.11 490 twitter stocktwits trandingview |
Health Technology
| | O: -0.24% H: 0.0% C: 0.0%
ALPMY | News | $9.53 690K twitter stocktwits trandingview |
Manufacturing
| | O: -1.22% H: 0.0% C: -0.72%
NVS | News | $98.12 3.15% 1.1M twitter stocktwits trandingview |
Health Technology
| | O: -0.46% H: 0.74% C: -0.19%
SNY | News | $47.375 0.48% 300K twitter stocktwits trandingview |
Health Technology
| | O: 0.74% H: 0.0% C: 0.0%
AMGN | News | $273.19 0.47% 360K twitter stocktwits trandingview |
Health Technology
| | O: -0.92% H: 0.63% C: -0.25%

america cancer treatment market
Gainers vs Losers
89% 11%

Top 10 Gainers
MTTR | News M | $4.65 167.24% 9.8M twitter stocktwits trandingview |

AGBA | $2.355 88.4% 34M twitter stocktwits trandingview |
Finance

EDBL | News | $6.75 79.52% 1.5M twitter stocktwits trandingview |

CZOO | $8.77 75.75% 11M twitter stocktwits trandingview |

VNRX | $0.84 40.0% 2.6M twitter stocktwits trandingview |
Health Technology

OPRT | News | $3.01 33.78% 6.8M twitter stocktwits trandingview |
Finance

MLEC | $1.81 29.29% 2M twitter stocktwits trandingview |
n/a

CMAX | $4.12 28.35% 65K twitter stocktwits trandingview |
Manufacturing

MTC | $2.0 28.21% 1.7M twitter stocktwits trandingview |
Technology Services

PEGY | $0.0586 27.95% 130M twitter stocktwits trandingview |
Manufacturing


Your saved searches
Save your searches and get alerts when important news are released.